Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants
Journal of Infectious Diseases
Saved in:
Main Authors: | Phua, K.B., Quak, S.H., Lee, B.W., Emmanuel, S.C., Goh, P., Han, H.H., De Vos, B., Bock, H.L. |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Conference or Workshop Item |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/129600 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants
by: Phua, K.B., et al.
Published: (2011) -
A short report on highlights of worldwide development of RIX4414: A Singaporean experience
by: Phua, K.B., et al.
Published: (2011) -
A rotavirus vaccine for infants: The Asian experience
by: Phua, K.B., et al.
Published: (2011) -
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study
by: Phua, K.B., et al.
Published: (2011) -
Immunogenicity, reactogenicity and safety of a diphtheria-tetanus-acellular pertussis-inactivated polio and Haemophilus Influenzae type b combination vaccine in a placebo-controlled rotavirus vaccine study
by: Kong, B.P., et al.
Published: (2016)